Mitogen- and stress-activated kinase 1 (MSK1), a downstream effector of p38 MAPK, modulates breast cancer dormancy by altering chromatin structure and reducing luminal differentiation gene expression (e.g., GATA3, FOXA1) (102). This evidence concerns the gene RPS6KA5 and breast cancer.